PRDS 2.16 (+0%)
US69945Q1058BiotechnologyBiotechnology

Pardes Biosciences (PRDS) Stock Highlights

2.16 | +0%
2023-10-05 13:05:13
Pardes Biosciences Inc is a clinical-stage biopharmaceutical company created for solving pandemic-sized problems, starting with COVID-19. It applies reversible-covalent chemistry to discover and develop novel oral drug candidates. The companys lead product candidate, PBI-0451, is being developed as a direct-acting, oral antiviral drug to treat and prevent SARS-CoV-2 infections, the virus responsible for COVID-19.

Statistics

Range Today
2.16 2.16
Volume Today 0
Range 1 Year
0.75 3.41
Volume 1 Year 79.96M
Range 3 Year
0.75 17.76
Volume 3 Year 156.16M
Range 10 Year
0.75 17.76
Volume 10 Year 156.16M

Highlights

Market Capitalization 133.95M (small)
Floating Shares 14.06M
Current Price 2.16
Price To Earnings -1.69
Price To Book 0.84
Earnings Per Share -1.28
Payout Ratio 0%

Performance

Latest 0%
1 Month +1.41%
3 Months +14.89%
6 Months +32.52%
1 Year -35.33%
3 Years -79.43%
5 Years -79.43%
10 Years -79.43%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.